GGrantIndex
Sort

326,823 grants matching clinical trial

ClinSeq - Clinical and Behavioral Aspects

$1,684,110
Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2019 · HG

The Biology of HIV Infections

$1,684,054
Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program

$1,683,955
Lorenzo Leggio · National Institute On Drug Abuse · ZID · FY2024 · DA

Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk

$1,683,861
Christine Marie Durand · Johns Hopkins University · U01 · FY2025 · AI

Chronic HIV infection and Aging in NeuroAIDS (CHAIN) Center

$1,683,828
Howard S. Fox · University Of Nebraska Medical Center · P30 · FY2014 · MH

THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT

$1,683,705
Oklahoma Medical Research Foundation · P50 · FY2004 · HL

Washington University Institute of Clinical and Translational Sciences (KL2)

$1,683,627
Kenneth S Polonsky · Washington University · KL2 · FY2008 · RR

Laboratory And Preclinical Studies Of Dengue Viruses

$1,683,606
Brian Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

MECHANISMS OF CELLULAR RESPONSES TO IONIZING RADIATION

$1,683,498
Georgetown University · P01 · FY2001 · CA

Etiology and Treatment of Alcohol Dependence

$1,683,485
Victor M Hesselbrock · University Of Connecticut Sch Of Med/Dnt · P60 · FY2015 · AA

Targeted Therapy in Neuroendocrine Cancer

$1,683,443
Samira Sadowski · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Oral Fluid NanoSensor Test (OFNASET)

$1,683,437
David T Wong · University Of California Los Angeles · U01 · FY2009 · DE

Impact of Smoking on Lung Cancer Chemoprevention

$1,683,417
University Of Texas Md Anderson Can Ctr · P01 · FY2004 · CA

Development of Novel Cancer Therapeutics by Targeting Sphingolipid Signaling

$1,683,403
Besim Ogretmen · Medical University Of South Carolina · P01 · FY2021 · CA

The Allogeneic Heart Stem Cell Trial in Hypoplastic Left Heart Syndrome Patients

$1,683,381
Luis Rodriguez-Borlado · Capricor, Inc. · UT2 · FY2016 · HL

Nutritional Primary Prevention of Type 1 Diabetes

$1,683,357
Dorothy J Becker · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · HD

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$1,683,177
Bradley A Evanoff · Washington University · UL1 · FY2011 · RR

ANCA Glomerulonephritis: From Molecules to Man

$1,683,140
Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2018 · DK

Community Clinical Oncology Program Research Base

$1,683,081
Walter John Curran · American College Of Radiology · U10 · FY2009 · CA

Automated Seizure Detection for Home Seizure Monitoring with Epilog Sensors

$1,683,078
Mark J. Lehmkuhle · Epitel, Inc. · U44 · FY2023 · NS

Lens β-Amyloid Biomarker for Early Detection of Preclinical Alzheimer's Disease in the Framingham Study

$1,682,982
Lee E Goldstein · Boston University Medical Campus · RF1 · FY2021 · AG

Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas

$1,682,938
Michael A Caligiuri · Ohio State University · P01 · FY2016 · CA

Etiology and Treatment of Alcohol Dependence

$1,682,796
Victor M Hesselbrock · University Of Connecticut Sch Of Med/Dnt · P60 · FY2016 · AA

Specialized Program of Translational Research In Acute Stroke at the Partners

$1,682,683
Karen L. Furie · Massachusetts General Hospital · P50 · FY2006 · NS

COALITION FOR HIV VACCINE DEVELOPMENT

$1,682,627
University Of Maryland Baltimore · U01 · FY2005 · AI